Yael Weiss built Mahzi Therapeutics to develop gene therapies for rare neurodevelopmental disorders.
Yael Weiss built Mahzi Therapeutics to develop gene therapies for rare neurodevelopmental disorders. Mahzi Therapeutics is pioneering a new biotech model by letting patients and families invest in the company. Half the early reservations for funding came from parents of rare-disease children.
Full founder directory · Investor directory · Company funding database · Fundraising library